External Source

Safely Switching From Natalizumab To Ocrelizumab In Patients With Ms At Risk Of Pml

2021 2:14
Synopsis
Natalizumab, an alpha-4-integrin-targeting monoclonal antibody, is a high efficacy treatment option for relapsing-remitting multiple ...

You Might Also Like

Comparing exit strategies in natalizumab-responders at high risk for PML 7:33
Comparing Exit Strategies In Natalizumab-responders At High ...
2021
Dr Paul Molyneux - Managing PML risk in patients treated with Natalizumab. 42:10
Dr Paul Molyneux - Managing Pml Risk In Patients Treated Wit...
2020
Challenges in switching from natalizumab in RRMS 1:55
Challenges In Switching From Natalizumab In Rrms
2023
Risk of PML in Patients Taking Natalizumab 2:03
Risk Of Pml In Patients Taking Natalizumab
2012
Tysabri PML Risk & Extended Interval Dosing 21:01
Tysabri Pml Risk & Extended Interval Dosing
2022
Risk Analysis of Natalizumab in Progressive Multifocal Leukoencephalopathy 8:18
Risk Analysis Of Natalizumab In Progressive Multifocal Leuko...
2014
A PML risk genetic test to identify at-risk patients on natalizumab 1:50
A Pml Risk Genetic Test To Identify At-risk Patients On Nata...
2023
Extending Natalizumab's Use Without Increasing Risk to MS Patients 2:06
Extending Natalizumab's Use Without Increasing Risk To Ms Pa...
2015
Extending Natalizumab's Use Without Increasing Risk to Patients 4:03
Extending Natalizumab's Use Without Increasing Risk To Patie...
2015
Monitoring a patient on natalizumab for JC virus 1:55
Monitoring A Patient On Natalizumab For Jc Virus
2013
What are the risks and benefits of Tysabri and who should take it? 3:42
What Are The Risks And Benefits Of Tysabri And Who Should Ta...
2016
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.